Please ensure Javascript is enabled for purposes of website accessibility

Why Core Labs Stock Slumped This Week

By Matthew DiLallo - Jun 17, 2021 at 3:53PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The oilfield services stock has cooled off after a big run.

What happened

Shares of Core Laboratories (CLB -0.84%) had declined 13.3% over the past week as of 3:15 p.m. EDT on Thursday. An analyst downgrade was the main factor weighing on the oil stock.  

So what

On Monday, an analyst from Citi downgraded shares of Core Labs from neutral to sell. The analyst also set their price target at $36 per share, still about 15% below the most recent price. 

The silhouette of some people pointing to an oil well.

Image source: Getty Images.

The Citi analyst made that call following an 80% year-to-date run-up in the oilfield service company's stock price. They felt the gain "appears overdone" given that Core trades at one of the lowest free cash flow yields in the oilfield service sector at 3.3% of 2022's projection. That implies it has one of the highest valuation multiples in its peer group. Because of that, Citi thinks there could be some near-term compression in the multiple.

It sees the potential for compression ahead because it believes that Core will post below-consensus second-quarter earnings. That led it to reduce its earnings outlook for Core Labs. Citi now expects the oilfield service company to report $18 million in EBITDA during the second quarter. That's down from its initial view of $20 million and below the analysts' consensus of $19 million. The bank also reduced its 2021 EBITDA forecast from $83 million to $79 million and 2022's outlook from $114 million to $109 million. 

Now what

Citi believes Core Labs stock has run up too far too fast. That's due partly to its belief that the company won't make as much money over the next 18 months as it initially expected. If Citi is right, shares could have further to fall, especially if Core does report disappointing second-quarter numbers.

Matthew DiLallo owns shares of Core Laboratories. The Motley Fool recommends Core Laboratories. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Core Laboratories N.V. Stock Quote
Core Laboratories N.V.
CLB
$16.45 (-0.84%) $0.14

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
379%
 
S&P 500 Returns
123%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 08/09/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.